We help you to develop a BP. A solid BP is conditional to manage a company effectively and for investors to participate. A second opinion is also possible.
In support of an exit/acquisition or buy/sell decision of product(s) we calculate a NPV based on realistic assumptions and risk management using in-dept market knowledge and experience.
We give advice about decisions like selling, licensing, or co-promotion. We can also act as an intermediate to search for the right partners and to close deals.
We develop a feasible strategy including a P&L. Decisions must be made about the primary market and main indication, competitive position, pricing and reimbursement, M&S organization, distribution, European launch, just to name a few.
We provide management support to drive commercial projects. If required, we can help to set up a legal entity, establish a European office, build commercial operations, and launch a new product.
We will develop a CDP aligned with your commercial strategy. Integration of science and business is required to take decisions about main indication and primary market. Also important is to fix the budget, registration strategy, health economics, protocol design, selection of EU centers and opinion leaders, to name a few.
We provide management support to drive clinical projects. If required, we help setting up a clinical department, outsourcing, CRO selection and monitoring, and investigator meetings.
Early adoption and eraly access programs may add considerable value. Some examples are compassionate use, “sell” science through courses, round tables, congresses and medical reps.
XCQTE aims for tailor-made services. Are you looking for specific services or want more information about services, please contact us for free advice. Talking costs nothing, but may produce big results.
“Everybody will notice when a game is not going well, but not many people are able to explain what is going wrong,
and only few are capable of fixing the problem” Johan Cruijff (famous Dutch soccer player and coach)
